War and humanitarianism, medicine and public health, rights and justice... Discover CRASH publications sorted by themes.
The fact that CRASH publications are written from an aid practitioner's, rather than researcher's, perspective, does not exempt them from the demands of rigorous research methods. We try hard at this, with the help of (volunteer) research professionals. The publications are not the MSF party line, but rather tools for reflexion based on MSF's framework and experience. They have only one purpose: to help us better understand what we are doing. Criticisms, comments and suggestions are more than welcome - they are expected.
Could a doctor working for a humanitarian organisation be sentenced to life imprisonment in the United States for having offered his “expert advice” to people linked to a “terrorist organisation”? That is what is feared by a number of civil rights’ organisations in the US since the Supreme Court declared on 21 June that the legislation known as the Material Support Statute was constitutional.
Rony Brauman criticises the International Criminal Court's indictment of the Sudanese president for genocide. If the prosecutor's argument is followed, humanitarian organisations working in the displaced people's camps should be charged with complicity in genocide.
Argued in the 1990s in the name of the "right or duty to intervene", the application of military might to rescue populations in danger is now debated with reference to the "Responsibility to Protect" paradigm (or "R2P" for those in the know). In this article Fabrice Weissman explains why MSF refuses to adhere to this doctrine of ‘just war', whose legalisation would effectively be legalising a new form of imperialism.
The ‘War crimes and politics of terror in Chechnya 1994-2004’ case study describes the constraints, questions and dilemmas experienced by MSF while speaking out during the two Russian-Chechen wars and the following years of ‘normalization’.
Four years after the Nigerian crisis, many things have changed in the nutrition field. This Cahier du Crash aims at considering this evolution and explore new possibilities for action for MSF.
Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.